Efficacy and safety of anaplastic lymphoma kinase inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis
General Info
Coverage type
Global
Time period covered
January, 2013 - December, 2021
Data type
Scientific literature
Keywords
Citation
Journal
Thorac Cancer
Pages
929-939
Publication year
2023
Suggested citation
Peng TR, Liao PF, Wu TW. Efficacy and safety of anaplastic lymphoma kinase inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis. Thorac Cancer. 2023; 14(10): 929-939.